Loading…
Embecta Corp. is projected to decline to $3.22 by 2027, a -1% move from its current price of $3.24. EMBC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $3.14 | $3.24 | $3.34 | -0.01% |
| Jul 13 | $3.10 | $3.24 | $3.38 | -0.03% |
| Jul 14 | $3.07 | $3.24 | $3.42 | -0.04% |
| Jul 15 | $3.04 | $3.24 | $3.44 | -0.05% |
| Jul 16 | $3.02 | $3.24 | $3.47 | -0.06% |
| Jul 17 | $3.00 | $3.24 | $3.49 | -0.08% |
| Jul 18 | $2.98 | $3.24 | $3.51 | -0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.98 | $3.24 | $3.51 | -0.09% |
| Week 2 | $2.88 | $3.23 | $3.63 | -0.18% |
| Week 3 | $2.81 | $3.23 | $3.72 | -0.27% |
| Week 4 | $2.74 | $3.23 | $3.80 | -0.36% |
| Week 5 | $2.69 | $3.23 | $3.87 | -0.45% |
| Week 6 | $2.64 | $3.22 | $3.94 | -0.54% |
| Week 7 | $2.59 | $3.22 | $4.00 | -0.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Embecta Corp. is a healthcare company described as a medical device company that provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. Its product lineup includes pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes.
It primarily sells its products to wholesalers and distributors, and it was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Embecta Corp. (EMBC) is a medical device company focused on diabetes management within the healthcare sector. It serves markets in the United States and internationally with a portfolio that includes pen needles, syringes, safety injection devices, and digital applications for diabetes management.
The stock currently trades at $3.19 per share and has a market capitalization of $189.26M, with a rank of 3855. The forecast suggests a rising long-term price path, with the 2026 average price at $3.19 rising to an average of $12.04 by 2050 and a maximum forecast of $23.84, implying an average ROI up to 277.4% by 2050.
A major floor 13.8% below — a decisive break under it would weaken the trend.
The nearest floor, 6.5% below — buyers have tended to step in here.
The nearest ceiling, 7.7% above — a clean break opens room to run.
A major ceiling 201.9% above — clearing it would confirm fresh momentum.
Key EMBC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EMBC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.25 | Sell | $3.24 | Sell |
| MA 10 | $3.30 | Sell | $3.25 | Sell |
| MA 20 | $3.20 | Buy | $3.30 | Sell |
| MA 50 | $3.74 | Sell | $4.24 | Sell |
| MA 100 | $6.55 | Sell | $6.04 | Sell |
| MA 200 | $9.63 | Sell | $8.32 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.25 | Neutral |
| Stoch RSI (14) | 79.55 | Neutral |
| CCI (20) | 25.16 | Neutral |
| Williams %R (14) | -54.35 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 3.51 | Buy |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 45.65 | Neutral |
| TRIX (15) | -0.86 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 49.85 | Neutral |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 3.20 | Buy |
| ADX (14) | 29.91 | Sell |
| ATR (14) | 0.10 | Info |
The 14-day RSI is 40, and overall market sentiment is NEUTRAL. The stock is trading below the 50-day simple moving average of $3.98 and well below the 200-day simple moving average of $9.74, indicating a lack of upside momentum in the near term. Support is at $3.03 and resistance at $3.49, with a 30-day price range from $2.57 to $3.95.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.90 | $3.24 | $3.94 | 0% | Neutral | |
| $2.53 | $3.22 | $4.35 | -1% | Neutral | |
| $2.69 | $3.53 | $4.97 | +9% | Neutral | |
| $3.21 | $4.33 | $6.29 | +34% | Bullish | |
| $3.37 | $4.65 | $6.94 | +43% | Bullish | |
| $3.19 | $4.49 | $6.86 | +39% | Bullish | |
| $3.18 | $4.57 | $7.14 | +41% | Bullish | |
| $3.15 | $4.62 | $7.35 | +43% | Bullish | |
| $3.44 | $5.13 | $8.30 | +58% | Bullish | |
| $3.97 | $6.03 | $9.91 | +86% | Bullish | |
| $4.51 | $7.41 | $13.02 | +129% | Bullish | |
| $6.91 | $13.04 | $25.27 | +303% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.90 | $3.24 | $3.95 | +0.00% |
| August 2026 | $2.74 | $3.25 | $3.96 | +0.22% |
| September 2026 | $2.68 | $3.20 | $3.95 | -1.38% |
| October 2026 | $2.74 | $3.29 | $4.10 | +2.72% |
| November 2026 | $2.71 | $3.28 | $4.12 | -0.41% |
| December 2026 | $2.56 | $3.11 | $3.94 | -5.13% |
Click any year to see its month-by-month EMBC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, EMBC could reach as high as $3.94, with a base case around $3.24 and support toward $2.90 — roughly 0% from $3.24. Price action looks broadly range-bound.
Expect EMBC to range from $2.53 to $4.35 through 2027. The $3.22 average target implies a -1% move from current prices. That is -1% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The EMBC price prediction for 2028 points to an average of $3.53 (low $2.69, high $4.97) — a potential gain of +9% on today's $3.24. Price action looks broadly range-bound.
In 2029, EMBC is projected to trade between $3.21 and $6.29, averaging $4.33 — a potential gain of +34% from today's $3.24. That is up +23% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Embecta Corp.'s 2030 outlook centres on $4.65, within a $3.37 to $6.94 range. That is up +7% on the projected 2029 average. That marks a +43% change versus current levels. Momentum favours further upside here.
By 2031, EMBC could reach as high as $6.86, with a base case around $4.49 and support toward $3.19 — roughly +39% from $3.24. Buyers look set to stay in control over this stretch.
Expect EMBC to range from $3.18 to $7.14 through 2032. The $4.57 average target implies a +41% move from current prices. That is up +2% on the projected 2031 average. Momentum favours further upside here.
The EMBC price prediction for 2033 points to an average of $4.62 (low $3.15, high $7.35) — a potential gain of +43% on today's $3.24. Buyers look set to stay in control over this stretch.
In 2034, EMBC is projected to trade between $3.44 and $8.30, averaging $5.13 — a potential gain of +58% from today's $3.24. That is up +11% on the projected 2033 average. Momentum favours further upside here.
Embecta Corp.'s 2035 outlook centres on $6.03, within a $3.97 to $9.91 range. That is up +17% on the projected 2034 average. That marks a +86% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, EMBC could reach as high as $13.02, with a base case around $7.41 and support toward $4.51 — roughly +129% from $3.24. Momentum favours further upside here.
Expect EMBC to range from $6.91 to $25.27 through 2050. The $13.04 average target implies a +303% move from current prices. That is up +76% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in EMBC today (≈ 308.641975 EMBC) could be worth
$4,025.13
+$3,025.13 (+303%) by 2050 · US Dollar
Based on the average projected EMBC price of $13.04 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EMBCwould be worth at today's price.
$1,000 invested in EMBC on Jul 10, 2025 (≈ 93.196649 EMBC) would be worth
$301.96
-$698.04 (-69.8%) today · 0.30× · US Dollar
Based on a EMBC entry price of $10.73 vs. today's $3.24.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.35 | $967.16 | -3.3% |
| 1 month ago | $3.21 | $1,009.35 | +0.9% |
| 3 months ago | $8.85 | $366.1 | -63.4% |
| 6 months ago | $12.85 | $252.14 | -74.8% |
| 1 year ago | $10.73 | $301.96 | -69.8% |
| All time (4.3y) ago | $47 | $68.94 | -93.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EMBC forecast.
Our base-case forecast reaches $6.50 around 2040.
Implied market cap at $6.50: $385.63M
The multi-year forecast shows a bullish trajectory beginning in the later 2020s, with the 2026 average price at $3.19 (min $2.90, max $3.86) and a 0% ROI, moving toward stronger gains in subsequent years. The 2027 forecast sits at an average $3.13 (min $2.44, max $4.26) with a -2% ROI, followed by 2028 at $3.38 (min $2.55, max $4.80) with 5.9% ROI. From 2029 onward the outlook turns more clearly bullish, with 2029 average $4.16 (min $3.06, max $6.11) and a 30.4% ROI, 2030 average $4.49 (min $3.22, max $6.78) and a 40.7% ROI, and continuing to rise through the early 2030s (2031 avg $4.29, max $6.64; 2032 avg $4.35, max $6.87; 2033 avg $4.38, max $7.06).
By 2034 the average is $4.80 with a 50.3% ROI, and 2035 shows $5.66 average and 77.5% ROI. The forecast accelerates further later, with 2040 average $6.86 and 115.1% ROI, and 2050 average $12.04 with a max of $23.84 and a 277.4% ROI. Sentiment is described as BULLISH in the 2029–2050 window, indicating a sustained positive outlook amid rising price forecasts.
These figures are estimates and not guarantees.
Tap a question to reveal the answer.
2030 avg $4.49, min $3.22, max $6.78; ROI 40.7%; sentiment BULLISH.
Forecasts show a bullish trajectory beginning in 2029, with 2029 avg $4.16, 2030 avg $4.49, and 2050 avg $12.04, plus a max of $23.84. ROI rises to 277.4% by 2050, with bullish sentiment in later years.
Yes, the 2050 forecast has an average of $12.04 and a max of $23.84, indicating a potential to surpass $10 within the forecast horizon.
$3.19 per share.
$189.26M.
Embecta Corp. Community Discussion
0Share your Embecta Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.